Baseline characteristics
ULCERATIVE COLITIS, CROHN'S DISEASE
A total of 28 participants were enrolled in the study, 2 participants were excluded after signing an informed consent and baseline bloodwork. One participants was unable to follow-up for the second research visit, and 1 participants was excluded because of the preintervention 6-MMP level >10,000 (Figure Consolidated Standards of Reporting Trials. 6-MMP, 6-methylmercaptopurine; AZA/6-MP, azathioprine/6-mercaptopurine.Schematic of the experimental protocol. It was determined whether participants took their azathioprine/6-mercaptopurine (AZA/6-MP) medication consistently in either an Participant characteristics6-MP, 6-mercaptopurine; AZA, azathioprine; CD, Crohn's disease; UC, ulcerative colitis.